ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,393,000 | -50.7% | 14,993 | -68.4% | 0.00% | -57.1% |
| Q3 2021 | $2,828,000 | -52.2% | 47,493 | -45.3% | 0.01% | -56.2% |
| Q2 2021 | $5,919,000 | -43.2% | 86,793 | -42.2% | 0.02% | -44.8% |
| Q1 2021 | $10,422,000 | +82.1% | 150,193 | +101.6% | 0.03% | +93.3% |
| Q4 2020 | $5,723,000 | +25.3% | 74,493 | +22.0% | 0.02% | +15.4% |
| Q3 2020 | $4,568,000 | +147.2% | 61,073 | +30.5% | 0.01% | +160.0% |
| Q1 2018 | $1,848,000 | -51.3% | 46,790 | -58.1% | 0.01% | -50.0% |
| Q4 2017 | $3,798,000 | -3.2% | 111,790 | -27.4% | 0.01% | -9.1% |
| Q3 2017 | $3,924,000 | +102.0% | 153,900 | +33.6% | 0.01% | +83.3% |
| Q2 2017 | $1,943,000 | – | 115,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |